Conversely, overexpression of LINC00330 in ESCC can suppress CCL2 expression, block the binding of CCL2 to CCR2 and activate its downstream signaling pathway to a certain extent, ultimately promoting a reduction in ESCC malignancy. Here, CCR2 is linked to esophageal squamous cell carcinoma.